Levalox

Levofloxacin, the active ingredient in Levalox, is a fluoroquinolone antibiotic presented as an intravenous solution for intravenous use. It treats a range of bacterial infections in adults, including community‑acquired and hospital‑acquired pneumonia, complicated urinary tract infections, skin and soft‑tissue infections, intra‑abdominal infections and bacterial prostatitis.

GNH USA supplies Levalox as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levalox is a fluoroquinolone antibiotic used to treat serious bacterial infections across several organ systems.

- Community‑acquired pneumonia: eradicates the causative pathogens and improves respiratory function. - Hospital‑acquired pneumonia: provides broad‑spectrum coverage for resistant organisms. - Complicated urinary tract infections: eliminates uropathogens in the upper and lower urinary tract. - Skin and soft‑tissue infections: resolves cellulitis, abscesses and other bacterial skin conditions. - Intra‑abdominal infections: targets mixed aerobic and anaerobic bacteria in the abdominal cavity. - Bacterial prostatitis: penetrates prostatic tissue to treat chronic bacterial infection.

Levalox may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Diarrhea: loose stools, occasionally watery. - Headache: transient cranial discomfort. - Dizziness: sensation of light‑headedness. - Rash: mild skin erythema or itching. - Elevated liver enzymes: transient increase in hepatic transaminases.

Serious or Rare Side Effects: - Tendon rupture: especially Achilles tendon, may occur without warning. - QT interval prolongation: can precipitate cardiac arrhythmias. - Clostridioides difficile infection: severe colitis risk. - Severe allergic reactions: anaphylaxis, angioedema. - Hepatic failure: rare but potentially life‑threatening. - Seizures: particularly in patients with CNS disorders.

Levalox requires careful assessment of patient risk factors and monitoring during therapy.

- Renal function: adjust therapy in patients with severe renal impairment. - History of tendon disorders: avoid use in individuals with prior tendon injury or tendon‑rupture risk. - Cardiac risk: monitor ECG in patients with known QT prolongation or electrolyte disturbances. - Concomitant NSAIDs or corticosteroids: increase risk of tendon rupture; use with caution. - Pregnancy and lactation: prescribe only when benefits outweigh potential risks. - Store at ambient temperature: keep in original container, protect from light and moisture.

Levalox can interact with several drug classes, requiring monitoring or avoidance.

Major Interactions (Avoid): - Co‑administration with other fluoroquinolones: additive toxicity. - Drugs that prolong QT interval (e.g., macrolides, antiarrhythmics): heightened arrhythmia risk. - Antacids or supplements containing aluminum, magnesium, calcium, or iron: reduce levofloxacin absorption.

Moderate Interactions (Monitor Closely): - Theophylline (CYP1A2 substrate): may increase serum theophylline levels. - Warfarin: monitor INR for potential anticoagulation changes. - Corticosteroids: observe for signs of tendon inflammation or rupture.